Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Patmore

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 7, 2023
Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectivesAnn Hewison, Eve Roman, Alexandra Smith, et al.
International Journal of Cancer|April 30, 2026
Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research NetworkEleanor Kane, Alexandra Smith, Debra Howell, et al.
Plos One|April 5, 2018
Myeloma: Patient accounts of their pathways to diagnosisDebra A Howell, Ruth I Hart, Alexandra G Smith, et al.
BMJ Supportive & Palliative Care|July 1, 2017
Determinants of hospital death in haematological cancers: findings from a qualitative studyDorothy McCaughan, Eve Roman, Alexandra G Smith, et al.
BMC Palliative Care|June 3, 2010
Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancyDebra A Howell, Eve Roman, Helen Cox, et al.
BJGP Open|December 12, 2019
Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research NetworkMaxine Je Lamb, Eve Roman, Debra A Howell, et al.
BMJ Supportive & Palliative Care|May 13, 2020
Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research networkRebecca Sheridan, Eve Roman, Alex G Smith, et al.
British Journal of Haematology|March 10, 2020
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survivalMark J Bishton, Simon Rule, William Wilson, et al.
Haematologica|March 20, 2025
Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Timothy Bagguley, Eve Roman, et al.
Cancer Epidemiology|December 31, 2023
Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research NetworkMaxine Lamb, Daniel Painter, Debra Howell, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 7, 2023
Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectivesAnn Hewison, Eve Roman, Alexandra Smith, et al.
International Journal of Cancer|April 30, 2026
Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research NetworkEleanor Kane, Alexandra Smith, Debra Howell, et al.
Plos One|April 5, 2018
Myeloma: Patient accounts of their pathways to diagnosisDebra A Howell, Ruth I Hart, Alexandra G Smith, et al.
BMJ Supportive & Palliative Care|July 1, 2017
Determinants of hospital death in haematological cancers: findings from a qualitative studyDorothy McCaughan, Eve Roman, Alexandra G Smith, et al.
BMC Palliative Care|June 3, 2010
Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancyDebra A Howell, Eve Roman, Helen Cox, et al.
BJGP Open|December 12, 2019
Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research NetworkMaxine Je Lamb, Eve Roman, Debra A Howell, et al.
BMJ Supportive & Palliative Care|May 13, 2020
Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research networkRebecca Sheridan, Eve Roman, Alex G Smith, et al.
British Journal of Haematology|March 10, 2020
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survivalMark J Bishton, Simon Rule, William Wilson, et al.
Haematologica|March 20, 2025
Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Timothy Bagguley, Eve Roman, et al.
Cancer Epidemiology|December 31, 2023
Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research NetworkMaxine Lamb, Daniel Painter, Debra Howell, et al.
Pageof 4